Paysign Inc
NASDAQ:PAYS

Watchlist Manager
Paysign Inc Logo
Paysign Inc
NASDAQ:PAYS
Watchlist
Price: 5.49 USD -0.54% Market Closed
Market Cap: 302.2m USD

Paysign Inc
Investor Relations

PaySign, Inc. engages in the provision of prepaid card programs and processing services for corporate, consumer and government applications. The company is headquartered in Henderson, Nevada and currently employs 80 full-time employees. The company went IPO on 2001-07-19. The firm provides a card processing platform consisting of systems and software applications based on the needs of its clients. The company markets its prepaid card solutions under its Paysign brand. Its Paysign platform provides a variety of services, including transaction processing, cardholder enrolment, value loading, cardholder account management, reporting, and customer service. The firm has developed prepaid card programs for corporate incentives and rewards, including but not limited to, consumer rebates and rewards, donor compensation, clinical trials, healthcare reimbursement payments, and pharmaceutical payment assistance. The firm manages all aspects of the prepaid card lifecycle, from the card design and approval processes with partners and networks, to production, packaging, distribution, and personalization.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q3 2025
Call Date
Nov 12, 2025
AI Summary
Q3 2025

Record Revenue: Paysign reported record Q3 revenue of $21.6 million, up 41.6% year-over-year, exceeding previous guidance.

Profit Growth: Net income rose 54% to $2.2 million, or $0.04 per share, and adjusted EBITDA increased 78% to $5 million.

Patient Affordability Surge: Patient Affordability revenue grew 142% to $7.9 million, now representing 36.7% of quarterly revenue.

Plasma Business Expands: Plasma revenue grew 12.4% to $12.9 million, with 595 active centers despite industry oversupply.

Margin Improvement: Gross profit margin rose 72 basis points to 56.3%, with further improvements expected as new centers mature.

Raised Guidance: Full-year 2025 revenue guidance raised to $80.5–$81.5 million and net income guidance increased to $7–8 million.

Operational Milestone: Opened a new 30,000 sq. ft. patient support center, quadrupling support capacity.

Key Financials
Revenue
$21.6 million
Net Income
$2.2 million
EPS
$0.04 per fully diluted share
Adjusted EBITDA
$5 million
Gross Profit Margin
56.3%
SG&A (excl. D&A and SBC) as % of Revenue
32.9%
Operating Expenses as % of Revenue
48.9%
Plasma Revenue
$12.9 million
Patient Affordability Revenue
$7.9 million
Number of Active Plasma Centers
595
Number of Active Patient Affordability Programs
105 at quarter end; 118 at end of October
Compensation and Benefits
$7.2 million
Number of Employees
222
Stock Compensation
$1.3 million
Depreciation and Amortization
$2.2 million
Fully Diluted Share Count
61.8 million (Q3); 59.76 million (2025 full year guidance)
Unrestricted Cash Balance
$16.9 million
Debt
zero
Earnings Call Recording
Other Earnings Calls

Management

Mr. Mark R. Newcomer
Co-Founder, President, CEO & Chairman
No Bio Available
Mr. Jeffery B. Baker
CFO & Treasurer
No Bio Available
Mr. Robert P. Strobo Esq.
General Counsel, Chief Legal Officer & Corporate Secretary
No Bio Available
Mr. Cosimo Cambi
Chief Operating Officer
No Bio Available
Mr. Brad Cunningham
Chief Technology Officer
No Bio Available
Mr. James McCroy
Executive Vice President of Strategic Development/IR
No Bio Available
Mr. Eric Trudeau
Chief Compliance Officer
No Bio Available
Mr. Dennis M. DiVenuta J.D.
Executive Vice President of Strategy & Corporate Development
No Bio Available
Alicia Ches
Director of Marketing
No Bio Available
Ms. Joan M. Herman
Executive VP of EFT Operations & Executive Director
No Bio Available

Contacts

Address
NEVADA
Henderson
2615 St. Rose Parkway
Contacts
+17024532221.0
paysign.com